The patient’s respiratory pattern and reproducibility are important factors affecting the accuracy of radiotherapy for lung cancer or liver cancer cases. Therefore, respiration training is required to induce respiration regularity before radiotherapy. However, the need for specialized personnel, space, and time-consuming training represent limitations. To solve these problems, we have developed a respiratory monitoring and training system based on a micro-electro-mechanical-system (MEMS) magnetic sensor. This system consists of a small attaching magnet, a sensor, and a breathing pattern output device. In this study, we evaluated the performance of the signal measurement in the developed system based on the various respiratory cycles, the amplitudes, and the position angles of the magnet and the sensor. The system can provide a more accurate breathing signal graph with lower measurement error and higher spatial resolution than conventional sensor methods by using additional magnet. In addition, it is possible the patient to monitor and train breathing himself by making it easy to carry and use without restriction of time and space.

Three-dimensional printing technology has the advantage of facilitating the construction of complex three-dimensional shapes. For this reason, it is widely used in medical and radiological fields. However, few materials with high electron density similar to that of bone exist for fabricating a human phantom. In this study, commercially available filament materials were used with an FDM 3D printer to perform delivery quality assurance (DQA) and were evaluated for medical use. For the bone filament material, BaSO₄ was synthesized in five ratios of 2%, 4%, 6%, 8%, and 10% with 40% PBAT and 50~58% PLA. The electron density for the 3D printing material fabricated was obtained using kV energy CT and compared with the electron density of human organs and bones. The radiation beam properties of the 3D printed structures were analyzed as films for treatment using a linear accelerator. As a result, by changing the infill density of the material, it was possible to produce a material similar to the density of human organs, and a homogeneous bone material with HU values ranging from 371 ± 9 to 1013 ± 28 was produced. The 3D printing material developed in this study is expected to be usefully applied to the development of a patient-specific phantom to evaluate the accuracy of radiotherapy.

The feasibility of proton minibeam radiation therapy (pMBRT) using a multislit collimator (MSC) and a scattering device was evaluated for clinical use at a clinical proton therapy facility. We fabricated, through Monte Carlo (MC) simulations, not only an MSC with a high peak-to-valley dose ratio (PVDR) at the entrance of the proton beam, to prevent radiation toxicity, but also a scattering device to modulate the PVDR in depth. The slit width and center-to-center distance of the diverging MSC were 2.5 mm and 5.0 mm at the large end, respectively, and its thickness and available field size were 100 mm and 76 × 77.5 mm², respectively. Spatially fractionated dose distributions were measured at various depths using radiochromic EBT3 films and also tested on bacterial cells. MC simulation showed that the thicker the MSC, the higher the PVDR at the phantom surface. Dosimetric evaluations showed that lateral dose profiles varied according to the scatterer’s thickness, and the depths satisfying PVDR = 1.1 moved toward the surface as their thickness increased. The response of the bacterial cells to the proton minibeams’ depth was also established, in a manner similar to the dosimetric pattern. Conclusively, these results strongly suggest that pMBRT can be implemented in clinical centers by using MSC and scatterers.

In radiation therapy (RT) for skin cancer, tissue-equivalent substances called boluses are widely used to ensure the delivery of an adequate dose to the skin surface and to provide a radioprotective effect for normal tissue. The aim of this study was to develop a new type of three-dimensional (3D) bolus for RT involving body parts with irregular geometries and to evaluate its clinical feasibility. Two 3D-printed boluses were designed for two patients with squamous cell carcinoma (SCC) of their distal extremities based on computed tomography (CT) images and printed with polylactic acid (PLA). The clinical feasibility of the boluses was evaluated by measuring the in vivo skin dose at the tumor site with optically stimulated luminescence detectors (OSLDs) and comparing the results with the prescribed and calculated doses from the Eclipse treatment planning system (TPS). The average measured dose distribution for the two patients was 94.75% of the prescribed dose and 98.8% of the calculated dose. In addition, the average measured dose during repeated treatments was 189.5 ± 3.7 cGy, thus demonstrating the excellent reproducibility of the proposed approach. Overall, the customized 3D-printed boluses for the RT of distal extremities accurately delivered doses to skin tumors with improved reproducibility.